Contrave led to a 4.1% greater weight loss than placebo in six randomized controlled trials with 9,949 participants
doi: 10.3389/fnut.2025.1667421 Received 16 July 2025 Accepted 30 September 2025 Published 05 December 2025 Volume 12 - 2025 Edited by Jianmei Li, Nanjing Normal University, China Reviewed by Rahul Kumar Singh, Banaras Hindu University, India Yun Li, Beijing Tiantan Hospital, China Updates Copyright 2025 Li, Yang, Zhang, Wang, Xu, Jiang, Chen, Wu and Qian
The pill has a strange smell to it but no weird taste, Paige said
I spent most of my life fighting a war with my body and chasing thinness
It discusses the evidence supporting the use of glucagon-like peptide-1 receptor agonists (GLP-1RA) as potential adjunctive therapy in T1D to reduce weight and improve insulin resistance